Spatiotemporal modulation of the evolutionarily conserved, intercellular Notch signaling pathway is important in the development of many animals. Examples include the regulation of neuralepidermal fate decisions in neurogenic ectoderm of Drosophila and somitogenesis in vertebrate presomitic mesoderm. In both these and most other cases, it appears that Notch-class transmembrane receptors are ubiquitously expressed. Modulation of the pathway is achieved primarily by the localized expression of the activating ligand or by alteration of receptor specificity through a glycosyl transferase. In contrast, we present this report of an instance where the abundance of the Notch-class mRNA itself is dynamically regulated. Taking advantage of the long cell cycle of the two-cellstage embryo of the leech Helobdella robusta, we show that this regulation is achieved at the levels of both transcript stability and transcription. Moreover, MAPK signaling plays a significant role in regulating accumulation of the transcript by virtue of its effect on Hro-notch mRNA stability. Intracellular injection of heterologous reporter mRNAs shows that the Hro-notch 3 UTR, containing seven AU-rich elements, is key to regulating transcript stability. Thus, we show that regulation of the Notch pathway can occur at a previously underappreciated level, namely that of transcript stability. Given that AU-rich elements occur in the 3 UTR of Notch-class genes in Drosophila, human, and Caenorhabditis elegans, regulation of Notch signaling by modulation of mRNA levels may be operating in other animals as well.
Spatiotemporal modulation of the evolutionarily conserved, intercellular Notch signaling pathway is important in the development of many animals. Examples include the regulation of neuralepidermal fate decisions in neurogenic ectoderm of Drosophila and somitogenesis in vertebrate presomitic mesoderm. In both these and most other cases, it appears that Notch-class transmembrane receptors are ubiquitously expressed. Modulation of the pathway is achieved primarily by the localized expression of the activating ligand or by alteration of receptor specificity through a glycosyl transferase. In contrast, we present this report of an instance where the abundance of the Notch-class mRNA itself is dynamically regulated. Taking advantage of the long cell cycle of the two-cellstage embryo of the leech Helobdella robusta, we show that this regulation is achieved at the levels of both transcript stability and transcription. Moreover, MAPK signaling plays a significant role in regulating accumulation of the transcript by virtue of its effect on Hro-notch mRNA stability. Intracellular injection of heterologous reporter mRNAs shows that the Hro-notch 3 UTR, containing seven AU-rich elements, is key to regulating transcript stability. Thus, we show that regulation of the Notch pathway can occur at a previously underappreciated level, namely that of transcript stability. Given that AU-rich elements occur in the 3 UTR of Notch-class genes in Drosophila, human, and Caenorhabditis elegans, regulation of Notch signaling by modulation of mRNA levels may be operating in other animals as well.
Helobdella ͉ leech ͉ mRNA turnover ͉ 3Ј UTR N otch signaling functions in a variety of developmental contexts in different embryonic and tissue systems (1) . The main framework of the pathway is evolutionarily conserved; thus, its many roles reflect cooption of an ancestral signaling pathway. Notch signaling regulates diverse functions such as neurogenesis and pattern formation in embryonic development. Regulation of the Notch signaling pathway has been studied extensively, with the conclusion that regulation of Notch itself occurs mainly at the translational or posttranslational levels (2, 3) . For example, in the eight-cell Caenorhabditis elegans embryo the notch homolog glp-1 is expressed uniformly in all of the cells; restriction of signaling is achieved by regulated translation of the glp-1 mRNA in a cell-specific manner (3). Posttranslation regulation of Notch is achieved by processes such as glycosylation (4) or by regulated degradation of the signal-transducing Notch intracellular domain (5) . Little is known about the regulation of notch mRNA itself.
Here, we report that both transcription and mRNA stability are involved in generating a dynamic pattern of Hro-notch mRNA expression in the two-cell embryo of the leech Helobdella robusta. The cellular simplicity and the long cell cycle of the two-cell leech embryo allowed us to address the temporal dynamics of Hro-notch mRNA stability in detail. Our demonstration of 3Ј UTR-regulated, oscillating expression of Notchclass transcript levels represents a previously uncharacterized mode of regulation of this ancient and ubiquitous signaling pathway. Furthermore, the presence of pentameric AU-rich elements (AREs) in the 3Ј UTR of Hro-notch as well as those from other species, and the correlation of Hro-notch expression with p38MAPK phosphorylation suggest that this mechanism may also be operative in other organisms. Such 3Ј UTRmediated transcript stability has been reported for mRNAs encoding cytokines (6) , but this work demonstrates that this mechanism can also operate for the Notch receptor. Previous studies have demonstrated a role for the ERK pathway in regulating Notch expression and signaling in Drosophila and C. elegans, respectively (7, 8) . The role of the p38MAPK pathway in regulation of Notch transcript levels, introduces another mode of cross-talk between two distinct signal-transduction pathways.
Results and Discussion
Helobdella development is characterized by determinate lineages, beginning with an unequal first cleavage. Prolonged cell cycles and the ability to stage embryos precisely (relative to polar body formation or the initiation of first cleavage) permit us to observe developmental events with good temporal resolution relative to the cell cycles and cell divisions during cleavage. The examination of such carefully timed embryos by in situ hybridization under identical reaction conditions reveals a dynamic pattern of Hro-notch mRNA levels during the two-cell stage. Hro-notch is present as a maternal transcript (Fig. 1A) , and in situ hybridization shows Hro-notch at uniform, basal levels in the zygote and in both blastomeres (AB and CD) at time points immediately after first cleavage (265-280 min after zygote deposition (AZD) (Fig. 1B) . Beginning Ϸ15 min after cytokinesis, however, the in situ signal starts to fluctuate in a reproducible manner, being stronger first in CD (in 78%; n ϭ 14 of 18 stained embryos at 280-295 min AZD; Fig. 1C ), and then in AB (in 84%; n ϭ 67 of 80 stained embryos at 305-325 min AZD; Fig. 1D ), and finally in CD again (in 58%; n ϭ 18 of 31 stained embryos at 340-355 min AZD; Fig. 1E ). We call these periods of biased expression the CD-1, the AB, and the CD-2 phases, respectively. Embryos fixed at most time points show a mix of staining patterns that we attribute to errors in timing, developmental noise, and the transition from one phase to another [ Fig.  1G ; and see supporting information (SI) Fig. 6 ). After the CD-2 phase, none of the embryos processed for in situ hybridization showed staining in either of the blastomeres (Fig. 1F) until the second cleavage. Hro-notch expression continues in various cells throughout cleavage (9) , but to analyze mechanisms regulating this dynamic expression pattern, we chose to take advantage of the cellular simplicity of the two-cell leech embryo, in which we have documented a similarly dynamic pattern of WNT protein expression and signaling (10) .
We hypothesized that this dynamic pattern of Hro-notch mRNA expression reflects a well regulated and cell-specific combination of differential mRNA stability and/or zygotic transcription. Comparing embryos fixed during the different phases and processed in parallel for in situ hybridization revealed that staining intensity of blastomere CD during the CD-1 phase is roughly comparable to the basal levels seen in the zygote and in both blastomeres immediately after first cleavage. This finding suggested that the CD-1 phase of cell-specific Hro-notch expression resulted from the loss of Hro-notch mRNA in cell AB. In contrast, staining in the AB and CD blastomeres during AB-1 and CD-2 phases, respectively, is more intense than the earlier staining. This observation, coupled with the reappearance of in situ signal after it has been lost in both AB and CD, suggests that the dynamic in situ pattern reflects zygotic transcription of Hro-notch, at least during the mid and late two-cell stage (305 min AZD onwards).
To test whether zygotic transcription is associated with the observed in situ hybridization pattern, we performed semiquantitative RT-PCR (sqRT-PCR) on precisely timed two-cell embryos, cultured either in medium containing a transcription inhibitor (500 g/ml of actinomycin-D in Htr medium containing 0.1% DMSO) or an equivalent concentration of DMSO alone. The DMSO-treated control embryos show a significant increase in Hro-notch mRNA during the AB and CD-2 phases of the two-cell stage relative to earlier time points, and actinomycin-D treatment abolishes this increase (Fig. 1H) . Similar results were obtained from embryos injected with another transcription inhibitor (␣-amanitin), and inhibitor-treated embryos show a decrease in the in situ staining associated with the AB and CD-2 phases (data not shown). These data indicate that the AB and CD-2 phases of Hro-notch expression are associated with accumulation of zygotic transcripts in AB and CD blastomeres, respectively, and that zygotic transcription contributes little to the CD-1 phase. Thus ,the CD-1 phase is a reflection of selective stabilization of maternal Hro-notch mRNA in blastomere CD relative to that in blastomere AB.
Differential mRNA stability is affected by intracellular factors that interact with structural elements commonly located within the 3Ј UTR of specific mRNAs (11) . The p38MAPK pathway has been implicated in regulating the stability of mRNAs bearing the pentameric AREs, AUUUA (6) . It has been proposed that p38MAPK inf luences the interaction between AREs and cytoplasmic factors by phosphorylating such transacting factors (12) (13) (14) (15) ; specifically, activated p38MAPK stabilizes ARE-bearing mRNAs by in- . Actinomycin-D has no effect on mRNA levels until after 300 min AZD (P Ͼ 0.05). U0126 treatment, however, induces a significant decline in the amount of Hro-notch mRNA starting from early stage 2 (P Ͻ 0.005). sqRT-PCR was done on groups of five embryos in each time window. Data shown are a compilation of a total of five experiments; at each time point, error bars represent standard error (SEM). (Scale bar: 100 m.)
hibiting ARE-mediated degradation (16) . Thus AREs can exert either a stabilizing or destabilizing effect on the mRNA molecule (17, 18) , depending on the p38MAPK activity within the cell. The strength of the effect varies with the number and configuration of AREs in the transcript (19) . Examination of the 3Ј UTR of Hro-notch (9) revealed seven pentameric AREs 5Ј to the polyadenylation element. Two of these AREs overlap and, with adjacent sequences, form two overlapping nonameric AREs, one with the sequence UUAUUUAUU and the other with the sequence UUAUUUAAA (Fig. 4E) . This configuration with overlapping nonameric AREs corresponds to a class 2 ARE configuration (20) . Class 2 ARE-bearing mRNAs, such as those encoding the cytokine Cox2, are known to destabilize the mRNA. This destabilization is counteracted by p38MAPK activity (21, 22) . Thus, Hro-notch mRNA, which also bears class 2 AREs in its 3Ј UTR, is a strong candidate for p38MAPK-regulated transcript stability.
To determine whether p38MAPK is activated in the two-cell leech embryo, we immunostained embryos with a commercially available antibody against the diphosphorylated form of p38MAPK (p38MAPKpp). Using an HRP-DAB protocol (see Materials and Methods) to visualize the immunostaining signal, we observed a dynamic pattern of p38MAPKpp immunoreactivity in the cytoplasm that parallels the three phases of Hro-notch mRNA expression and, thus, is consistent with a role for p38MAPKpp in posttranscriptional mRNA regulation ( Fig. 2 A-C) .
The immunostaining pattern was reproducible and was seen with two different coloration times (Fig. 2 A-C and AЈ-CЈ). However, as has been seen in other whole-mount MAPKpp immunostaining experiments (23), the difference in staining intensity between the immunopositive and immunonegative cells was relatively low. To further examine the differential activation of p38MAPK, we also tested for nuclear translocation of p38MAPKpp. For this purpose, we let a few embryos from each reaction undergo longer coloration reactions, so as to allow the visualization of the nucleus through the yolk-rich cytoplasm. Such embryos showed nuclear localization of p38MAPKpp in phase with Hro-notch expression and cytoplasmic p38MAPKpp (Fig. 2 AЈ-CЈ) . To unequivocally confirm the presence of nuclearly localized p38MAPKpp, we sectioned these embryos and counterstained the sections with a fluorescent DNA stain (4Ј, 6-diamidino-2-phenylindole; DAPI), which normally causes nuclei to fluoresce brightly. In the nuclei of p38MAPKpp immunopositive cells, however, the fluorescence was quenched by the precipitate used to visualize the antibody (Fig. 2 D-G) . The nuclear translocation of p38MAPKpp, as judged by fluorescence quenching, correlated with the pattern of cytoplasmic staining, supporting the conclusion that the temporal dynamics of p38MAPK phosphorylation mirror Hro-notch mRNA expression. Is there a causal link underlying the coincident patterns of p38MAPK activation and Hro-notch accumulation in the twocell embryo?
To address this question, we performed sqRT-PCR on embryos cultured in the presence of the MAPKK inhibitor U0126 (50 M in medium containing 0.1%DMSO). U0126 is widely used as an inhibitor of the ERK kinase (MKK1/2) but also inhibits MKK3/6, the MAPKK responsible for phosphorylation of p38MAPK (24) . U0126 treatment, when initiated anytime before stage 4a (7 h AZD) resulted in specific defects in late cleavage (Ϸ33 h AZD) (F.C.G., and Ajna S. Rivera, unpublished work) and reduced p38MAPKpp immunoreactivity as measured by Western blot analysis during stage 7 (50 h AZD; SI Fig. 7 , and data not shown, and SI Supporting Text). Correlated with these effects, we found that UO126 treatment reduced the accumulation of Hro-notch mRNA relative to vehicle-treated control embryos as judged by sqRT-PCR (Fig. 1H) . In particular, U0126-treated embryos showed a statistically significant decline in the amount of transcript during the CD-1 phase that was not seen with the transcription inhibitor, actinomycin-D. This result is consistent with our prediction that the CD-1 phase of Hro-notch in situ hybridization is due to selective stabilization of maternally inherited Hro-notch transcript in blastomere-CD by p38MAPKpp.
Thus, we conclude that the dynamic Hro-notch in situ pattern in the two-cell Helobdella embryo results from MAPK-mediated regulation of Hro-notch transcript stability and is also due to activation of zygotic transcription by an as yet unknown signal. The effect of U0126 on blocking Hro-notch accumulation during the AB and CD-2 phases is consistent with the possibility that MAPK signaling also activates zygotic transcription of Hronotch, but our experiments do not distinguish between this possible role for MAPK in transcriptional activation and its demonstrated role in transcript stabilization. Moreover, these results do not rule out possible contributions of MAPK pathways other than p38MAPK in this process. In particular, given the U0126 results, it seemed reasonable to consider that ERK signaling also played a role in activating Hro-notch transcription during late stage 2, as has been shown for Drosophila (7) . However, we were unable to detect phosphorylated ERK by using a monoclonal Ab specific for the phosphorylated protein.
To test the hypothesis that the 3Ј UTR of Hro-notch is sufficient for the observed expression pattern in the two-cell embryo, we injected zygotes with egfp::N3Ј UTR-pae, a reporter mRNA containing eGFP coding sequence, the 3Ј UTR of Hro-notch and an SV40 polyadenylation element (PAE) to prevent degradation of nonpolyadenylated mRNA (25, 26) . As a control, we injected mRNA containing eGFP and PAE sequences only (egfp-pae). We chose to analyze the in situ pattern of the exogenous egfp mRNA at 275Ј, 285Ј, 310Ј, and 350Ј (to represent Pre-CD1, CD-1, AB, and CD-2 phases of Hro-notch, respectively), because these time points showed the most robust and least variable staining of Hro-notch during the respective phases (SI Fig. 6 ). Using in situ hybridization for egfp to follow the injected mRNAs after first cleavage, we found that, in embryos injected with egfp-pae, blastomeres AB and CD stain with equal intensities at all time points, and the in situ signal showed a gradual decline over time (n ϭ 49) (Fig. 3 A-D) . In contrast, the staining pattern in embryos injected with egfp::N3Ј UTR-pae recapitulated the early portion of the dynamic Hronotch pattern (Fig. 3 AЈ and BЈ) . AB and CD stained equally in most of the embryos fixed soon after cleavage. Staining was lost from AB in a significant number (Ϸ30%) of embryos by time points corresponding to the CD-1 phase (Fig. 3CЈ ) and was lost in both cells in most (Ϸ71%) of the embryos by the beginning of CD-2 phase (Fig. 3DЈ) . A significant number of embryos during the CD-1 and AB phases retained staining in both cells; we attribute this to the variability in the amount of mRNA delivered intracellularly, which might be above physiologically relevant concentrations in these embryos. Notwithstanding this observation, we point out that none of the embryos showed detectable staining in blastomere AB after the onset of the CD-1 phase, which reflects the rapid degradation of the mRNA in blastomere AB as compared with that in blastomere CD. This finding suggests that the Hro-notch 3Ј UTR targets the reporter mRNA molecule for degradation and that egfp::N3Ј UTR-pae mRNA is selectively stabilized in the cell with activated p38MAPK. Moreover, the disappearance of egfp::N3Ј UTR-pae reporter mRNA during the CD-2 phase further corroborates the interpretation that the Hro-notch in situ signal during this time is indeed due to the accumulation of zygotic transcript.
As a further test of the hypothesis that p38MAPKpp signaling inhibits ARE-mediated degradation of endogenous Hro-notch mRNA, we injected zygotes with in vitro-transcribed Hro-notch 3Ј UTR. We predicted that the synthetic mRNA would compete with endogenous transcripts for binding the postulated p38MAPKpp-activated stabilization factors, thereby destabilizing the endogenous transcripts. As predicted, the in situ signal for endogenous Hro-notch, during the AB and CD-2 phases, was reduced in most embryos injected with the 3Ј UTR (Fig. 4 C and  D) compared with those injected with water ( Fig. 4 A and B) . Using sqRT-PCR to quantify this result, we measured roughly equivalent reductions of endogenous Hro-notch mRNA (26% and 32% in the AB and CD-2 phases, respectively) in embryos injected with Hro-notch 3Ј UTR relative to those injected with water (data not shown). The observed level of transcript reduction reflects the balance between enhanced degradation and ongoing transcription. It should be noted that the sqRT-PCR measurements underestimate the extent of the reduction because they were carried out on pools of five embryos each for which the success of the mRNA injections could not be ascertained. These results suggest that even the later (AB and CD-2) phases of Hro-notch accumulation reflect the competing dynamics of mRNA transcription, stabilization, and degradation. It appears that when this dynamic is disrupted by the introduction of exogenous Hro-notch 3Ј UTRs that effectively sequester the available stabilization factors, endogenous Hro-notch mRNA is targeted for degradation by virtue of the presence of the AREs in its 3Ј UTR.
In conclusion, we show that transcript levels of a Notch-class gene (Hro-notch) oscillate antiphasically in the AB and CD blastomeres of the two-cell embryo in the leech H. robusta, i.e., high transcript levels in AB are associated with low levels in CD and vice versa (Fig. 5) . Moreover, the Hro-notch levels are controlled by dynamic activation of one or more of the MAPK (p38MAPK and ERK) signaling pathways. Initially, the Hronotch level in each cell reflects primarily inherited maternal transcripts. Later, the production and turnover of zygotic transcripts becomes important. The 3Ј UTR of Hro-notch mRNA confers a relatively short half-life to the transcripts, apparently because of the presence of multiple AREs. This instability is , were fixed at time points corresponding to the color-coded phases of Hro-notch expression (see Fig. 1 ) and then processed by in situ hybridization for egfp. egpf-pae mRNA is inherited uniformly by blastomeres AB, and CD and is largely stable in both the cells through the two-cell stage. egfp::N3Ј UTR-pae mRNA is inherited equally by blastomeres AB and CD at first cleavage (A') but shows more pronounced degradation in blastomere AB during the CD-1 phase (compare B and BЈ). The egfp::N3Ј UTR-pae mRNA is cleared from blastomere AB by the AB phase (CЈ) and is mostly degraded in blastomere CD by the CD-2 phase (DЈ). (E) Numerical distribution of in situ hybridization patterns for egfp in embryos injected with egfp-pae or egfp-N-3Ј UTR-pae. Note that none of the embryos injected with egfp::N3Ј UTR-pae mRNA showed a stronger signal in AB than in CD. All embryos (except A and AЈ) were processed for in situ hybridization simultaneously. Coloration reaction for all embryos was limited to 10 min at room temperature in the dark. (Scale bar: 100 m.)
counteracted by the p38MAPK pathway. Thus, the Hro-notch transcript levels are controlled by MAPK signaling at the level of transcript stability and possibly also at the level of transcription. This link between the p38MAPK and Notch pathways persists into later development, because we have observed coincident p38MAPK activation and Hro-notch mRNA accumulation in the ectodermal precursor cell DNOPQ (SI Fig. 8) .
Another instance where p38MAPK plays a role in early development is in the axial patterning of the Drosophila oocyte, where it regulates the availability of the EGF ligand (encoded by gurken) and thus controls the activation of the ERK pathway in the follicle cells (27) . Although the mechanistic intricacies of combinatorial effects between p38MAPK and other signaling pathways remain to be elucidated, our observations suggest that these effects might involve the regulation of mRNA stability. It has already been demonstrated that oscillations in Notch signaling can be achieved by modulating transcript levels for the presumptive ligand (deltaC, in fish presomitic mesoderm) and for a receptor glycosylating enzyme (lunatic fringe, in chick PSM) (28, 29) . Our results reveal yet a third mechanism by which oscillatory modulation of Notch signaling may be achieved, namely regulating transcript levels for Notch receptor itself in the two-cell leech embryo. Does this mechanism of Notch regulation operate in other organisms as well? This question can only be answered empirically, but we note that Notch-class genes in a variety of organisms bear several pentameric AREs in their 3Ј UTRs (Fig. 4E) . In particular, the 3Ј UTR of human Notch-1, like that of Hro-notch, bears nonameric AREs, which makes it a strong candidate for regulation by p38MAPK. The occurrence of AREs within the 3Ј UTRs of other Notch genes could be a mere coincidence, and the regulation of Notch transcript stability by p38MAPK could be a novelty restricted to leech. This would be a noteworthy result in and of itself, given the frequency with which genes and signaling pathways discovered in one organism prove to have broadly distributed homologs. A more likely alternative, in our opinion, is that our observations provide a relatively prominent, experimentally accessible example of a regulatory interaction that operates throughout the animal kingdom.
Materials and Methods
In Situ Hybridization. Freshly laid zygotes (Helobdella sp. collected from Austin, TX) cultured in Htr medium and timed starting from the appearance of the first cleavage furrow were synchronized by grouping embryos that finished first cleavage within 5 min of each other. All in situ hybridizations were carried out 
